1093879-46-9 Usage
Description
2-(6-bromopyridin-2-yl)acetic acid is an organic compound with the molecular formula C7H6BrNO2. It features a bromo substituent on the pyridine ring and a carboxylic acid functional group. This molecule is known for its potential applications in the pharmaceutical and chemical industries due to its unique structural properties.
Uses
Used in Pharmaceutical Industry:
2-(6-bromopyridin-2-yl)acetic acid is used as a key intermediate in the synthesis of pyrimidine derivatives, which are known as RORγ modulators. These modulators play a crucial role in regulating the RORγ protein, a potential target for treating various inflammatory and autoimmune diseases. By modulating RORγ, these pyrimidine derivatives can help in the development of novel therapeutics for conditions such as rheumatoid arthritis, multiple sclerosis, and inflammatory bowel disease.
Used in Chemical Synthesis:
In the field of chemical synthesis, 2-(6-bromopyridin-2-yl)acetic acid can be utilized as a building block for the creation of more complex molecules with diverse applications. Its unique structural features make it a valuable component in the design and synthesis of new compounds with potential uses in various industries, including pharmaceuticals, agrochemicals, and materials science.
Check Digit Verification of cas no
The CAS Registry Mumber 1093879-46-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,9,3,8,7 and 9 respectively; the second part has 2 digits, 4 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1093879-46:
(9*1)+(8*0)+(7*9)+(6*3)+(5*8)+(4*7)+(3*9)+(2*4)+(1*6)=199
199 % 10 = 9
So 1093879-46-9 is a valid CAS Registry Number.
1093879-46-9Relevant articles and documents
SHMT INHIBITORS AND USES THEREOF
-
Paragraph 00239, (2018/06/30)
The present invention provides compounds, compositions thereof, and methods of using the same.
COMPOUNDS FOR TREATMENT OF IMMUNE AND INFLAMMATORY DISORDERS
-
Paragraph 0784, (2017/03/14)
Compounds, methods of use, and processes for making inhibitors of complement Factor D are provided comprising Formula I, I" and I'" or a pharmaceutically acceptable salt or composition thereof. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade. The inhibitors of Factor D described herein reduces the excessive activation of complement.
